Almirall SA operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Almirall SA with three other
pharmaceutical manufacturers in Europe:
sales of 775.77 million Euro [US$865.82 million]
of which 48%
(675.61 million Euro [US$754.03 million]
of which 100%
was Pharmaceuticals), and
based in France
(871.83 million Euro [US$973.02 million]
of which 58%
was Companion Animals).
Almirall SA reported sales of 764.36 million Euro (US$853.08 million)
December of 2016.
increase of 11.6%
versus 2015, when the company's sales were 684.99 million Euro.
Despite this increase, sales are still
below the level achieved in 2014, when Almirall SA
reported sales of 786.40 million Euro.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Almirall SA had sales
of 768.42 million Euro.
Sales of Licenses saw an increase
that was more than double the company's growth rate: sales were up
126.5% in 2016, from
40.13 million Euro to 90.89 million Euro.
Almirall SA also saw significant increases in sales in
Dermatology (up 35.6% to 203.39 million Euro)
Not all segments of Almirall SA experienced an increase in sales in 2016:
sales of Own Network (Spain) fell 5.1% to 448.12 million Euro.
Almirall SA also experienced decreases in sales in
Corporate (down 3.7% to 21.96 million Euro)